SSRI Emotional Blunting: Understanding, Recognizing, and Restoring Your Emotional Life on Antidepressants

Introduction: When the Cure Comes With a Cost

You started taking an antidepressant hoping to feel better. And in many ways, you do. The crushing sadness has lifted. The anxiety isn’t as overwhelming. You can function again.

But something else has changed too. You’re not exactly sad anymore, but you’re not really happy either. Moments that should bring joy feel muted. Things that would have made you cry before barely register now. You might describe yourself as “fine” or “okay,” but secretly you wonder: is this really what feeling better is supposed to feel like?

If this resonates with you, you may be experiencing what’s called emotional blunting, a common but underrecognized side effect of SSRI and SNRI antidepressants. Studies suggest that between 40% and 60% of people on these medications experience some degree of emotional dampening. Some research puts the figure even higher.

This guide will help you understand what emotional blunting is, why it happens, how to tell if your experience is medication-related or something else, and what evidence-based options exist for restoring your emotional range while maintaining your mental health.

Part 1: What Is Emotional Blunting?

Defining the Experience

Emotional blunting describes a dampening or restriction of the normal range of human emotions. Rather than the intense lows of depression, people experiencing emotional blunting often describe feeling “flat,” “muted,” “numb,” or like they’re watching life through glass.

The experience can include:

Dampened positive emotions: Joy, excitement, enthusiasm, and pleasure feel less intense or harder to access. You might look forward to something, find it fine in the moment, but notice it doesn’t bring the spark it once would have.

Dampened negative emotions: This aspect can initially feel like a benefit. Situations that would have caused significant distress now feel more manageable. But over time, the inability to feel appropriately sad, angry, or worried can feel just as problematic as the inability to feel happy.

Restricted emotional range: The emotional “dial” that used to go from 1 to 10 now seems stuck between 4 and 6. Highs aren’t as high; lows aren’t as low. Everything feels moderate, middle, neutral.

Reduced emotional responsiveness: Events that should trigger strong emotions don’t. A touching movie doesn’t move you. Good news doesn’t excite you. Achievements feel hollow. Losses don’t hurt the way they should.

Feeling disconnected: Some people describe a sense of watching their own life rather than living it, or feeling emotionally distant from people they love.

How Common Is It?

Emotional blunting is far more common than most patients or even providers realize. Studies using careful assessment methods find that:

• Between 40% and 60% of people on SSRIs or SNRIs report some degree of emotional blunting
• Some studies using comprehensive measures report rates as high as 92% experiencing clinically significant apathy
• Sexual dysfunction and emotional blunting frequently occur together, suggesting related mechanisms

The wide range in reported prevalence reflects differences in how studies measure the phenomenon. When patients are directly asked specific questions about emotional changes, rates are much higher than when researchers simply count spontaneous reports.

The Paradox of Treatment

Here’s what makes emotional blunting particularly challenging: it often appears after the antidepressant has successfully treated depression.

During depression, many people experience anhedonia (inability to feel pleasure) and emotional pain as core symptoms. When the medication starts working, the pain lifts, which is the goal. But for some people, what emerges isn’t a return to normal emotional life. Instead, there’s a kind of emotional flatness that’s different from depression but also different from how they felt before becoming depressed.

This timing creates confusion. Patients often aren’t sure if something is wrong or if this is simply what “not being depressed” feels like. They may assume they should be grateful to feel okay and shouldn’t complain about not feeling great.

The truth is that emotional blunting represents a side effect, not the treatment goal. Relief from depression should include the ability to experience the full range of human emotions, including genuine happiness, not just the absence of intense suffering.

Part 2: Why Does Emotional Blunting Happen?

Understanding the mechanism helps explain both why this side effect occurs and why certain treatments help.

The Serotonin Connection

SSRIs work by increasing serotonin levels in the brain. This helps with depression and anxiety, but serotonin is involved in much more than mood. It plays a complex role in emotional processing.

Research suggests that increased serotonin activity may affect how the brain processes emotional information. Functional imaging studies show that SSRIs can reduce activity in brain regions involved in processing both positive and negative emotional stimuli.

In other words, the medication may be doing exactly what it’s supposed to do for depression (reducing negative emotional processing) while also doing something unwanted (reducing positive emotional processing).

The Dopamine Connection

Serotonin and dopamine have a complex relationship in the brain. Increased serotonin activity can, in some circumstances, suppress dopamine activity.

Dopamine is crucial for motivation, reward, pleasure, and emotional engagement with life. If SSRI-induced serotonin increases lead to relative dopamine decreases, this could explain why people feel less motivated, less enthusiastic, and less emotionally responsive.

This mechanism also helps explain why dopaminergic medications like bupropion can help counteract emotional blunting.

The 5-HT2 Receptor Story

Specific serotonin receptors, particularly the 5-HT2 family, appear to play a role in emotional blunting. When these receptors are stimulated by increased serotonin, they may contribute to emotional dampening.

This matters because different medications affect these receptors differently. Medications that block 5-HT2 receptors (like mirtazapine and, to some extent, vortioxetine) may cause less emotional blunting than pure SSRIs.

Individual Variation

Not everyone experiences emotional blunting on SSRIs. Why do some people maintain their emotional range while others become flat?

The answer likely involves genetic variations in how individuals metabolize medications and how their serotonin systems are configured. Some people may be more susceptible to the emotional-dampening effects while others are relatively protected.

We can’t yet predict who will experience emotional blunting before starting medication, which is why monitoring for this side effect and being willing to adjust treatment is important.

Part 3: Is It the Medication or Is It Depression?

One of the most challenging aspects of emotional blunting is distinguishing it from depression itself. Both conditions involve changes in emotional experience, and they can coexist. Getting this differentiation right matters because the treatment approaches are different.

The Diagnostic Puzzle

Depression commonly causes:

• Low, sad, or empty mood
• Anhedonia (inability to feel pleasure)
• Lack of interest in activities
• Fatigue and low motivation
• Feeling disconnected from life

Medication-induced emotional blunting commonly causes:

• Flat, muted, or neutral mood
• Reduced intensity of both positive and negative emotions
• Ability to engage in activities but without the usual emotional payoff
• Feeling “fine” but not “good”
• Sense of emotional distance or numbness

As you can see, there’s overlap. Both involve changes in emotional experience and engagement with life. So how do you tell them apart?

Key Differentiating Features

Timing is the most important clue.

If emotional difficulties were present before you started medication and persist after starting, depression is likely playing a significant role. If emotional engagement was relatively normal before medication, started at a certain point after beginning or increasing your dose, and changed when the medication changed, the medication is the more likely culprit.

Ask yourself: Was I able to feel happy, excited, or deeply moved before I started this medication? Did that change after starting?

The quality of the emotional experience differs.

Depression typically involves negative mood states: sadness, hopelessness, emptiness, guilt, worthlessness. Even when depressed people feel “nothing,” there’s often an underlying current of pain or heaviness.

Medication-induced emotional blunting more often involves a true neutral state. The heaviness of depression may be gone, but so is the lightness of joy. People often describe it as “fine” or “okay” rather than “bad” or “empty.”

Interest versus engagement shows different patterns.

In depression, people often lose interest in activities altogether. Things that used to matter don’t seem to matter anymore.

With emotional blunting, interest may be preserved, but emotional engagement is reduced. You might still want to see your friends, enjoy a meal, or accomplish goals, but the emotional satisfaction when you do these things feels muted.

Drive versus emotional response distinguishes them.

True apathy (which can occur with depression or as a medication effect) involves reduced drive and initiative. People with apathy don’t initiate activities; they’re passive.

Emotional blunting often preserves drive and initiative while dampening the emotional response. You still do things; you just don’t feel as much about them.

A Practical Framework

Consider creating a simple timeline:

1. How was your emotional life before you became depressed?
2. How did it change when you became depressed?
3. How did it change when you started your current medication?
4. How does it respond to dose changes?

If your emotional life improved when you started medication (less sadness, less anxiety) but then reached a plateau of “flatness” that doesn’t feel like your pre-depression self, the medication is likely contributing.

If you still experience sadness, hopelessness, or emptiness despite medication, residual depression is likely still present.

If both patterns are present, you may be dealing with partial response to treatment and medication-induced emotional blunting, which is actually common.

When Both Are Present

Many people experience a combination: their depression is partially treated (the worst symptoms are better), but residual depression symptoms remain, and on top of that, the medication is causing some emotional blunting.

This combination requires a nuanced approach that addresses both the undertreated depression and the medication side effect. Simply increasing the dose might help the depression but worsen the blunting. Simply reducing the dose might help the blunting but worsen the depression.

This is where strategies like augmentation with bupropion can be particularly valuable: they can address both issues simultaneously.

Part 4: The Impact of Emotional Blunting

Understanding why emotional blunting matters helps motivate addressing it rather than simply accepting it.

Effects on Relationships

Emotional blunting can significantly impact close relationships. Partners may perceive the blunted person as distant, uncaring, or disengaged. The person experiencing blunting may struggle to respond emotionally in ways their loved ones expect and need.

“I know I should feel more excited about my daughter’s graduation,” one patient might say. “I can see how important it is, but I just can’t access that feeling. My wife noticed I seemed detached, and I couldn’t explain why.”

This emotional unavailability, even when not intentional, can create distance in relationships and may be misinterpreted as a sign that the person doesn’t care.

Effects on Creativity and Work

Many people report that emotional blunting affects their creativity. The spark of inspiration, the passion for projects, the emotional investment in work may all diminish.

For people in creative fields, this can be particularly devastating. But it affects anyone whose work benefits from enthusiasm, emotional engagement, or creative problem-solving.

Effects on Life Satisfaction

Paradoxically, emotional blunting can reduce quality of life even while treating depression. People may find themselves no longer suffering intensely but also not truly enjoying life. This “okay but not good” state can feel like a different kind of trap.

Some patients describe feeling like they’re going through the motions of life without really living it.

Effects on Medication Adherence

Emotional blunting is a significant contributor to people stopping their antidepressants. When the trade-off becomes “depressed but feeling things” versus “not depressed but feeling nothing,” some people choose to stop medication, putting themselves at risk for depression relapse.

This is an unnecessary choice. With proper attention to this side effect, most people can find a treatment approach that controls depression while preserving emotional richness.

Part 5: Strategies for Restoring Emotional Range

If you’ve determined that emotional blunting is affecting you, several evidence-based strategies can help. The goal is to restore your emotional range while maintaining the mood benefits you’re getting from treatment.

Strategy 1: Dose Reduction

Since emotional blunting can be dose-related, the simplest intervention is often reducing the medication dose.

How it works: A lower dose may still provide antidepressant benefits while reducing the emotional-dampening effect.

Evidence: While no large trials have specifically studied dose reduction for emotional blunting, clinical experience and the dose-dependent nature of serotonergic effects support this approach.

Considerations: The risk is that reducing the dose may allow depression symptoms to return. This approach works best for people whose depression is well-controlled and who may be on a higher dose than necessary.

Practical approach: Any dose reduction should be gradual and done in collaboration with your provider. Monitor your mood carefully during and after the reduction. Have a plan for what to do if depression symptoms re-emerge.

Strategy 2: Switching Antidepressants

If dose reduction isn’t feasible or doesn’t help, switching to a medication with a lower emotional-blunting profile may be effective.

Bupropion (Wellbutrin) is often the first consideration for switching. It works through dopamine and norepinephrine rather than serotonin, which means it doesn’t cause the serotonergic emotional blunting that SSRIs can. Many patients report feeling “more like themselves” on bupropion, with preserved emotional range.

However, bupropion is less effective for anxiety than SSRIs and can be too activating for some people. It’s not appropriate if you have a history of seizures or certain eating disorders.

Vortioxetine (Trintellix) has a unique mechanism that includes 5-HT3 antagonism, which may contribute to less emotional blunting. Open-label studies have shown improvement in emotional blunting when patients switch to vortioxetine. It maintains SSRI-like antidepressant effects while potentially causing less emotional dampening.

Mirtazapine (Remeron) blocks 5-HT2C receptors rather than increasing serotonin reuptake inhibition. This mechanism is theoretically less likely to cause emotional blunting. The significant trade-offs are weight gain and sedation.

Agomelatine (not available in the US but used in Europe and elsewhere) has a unique mechanism involving melatonin receptors and 5-HT2C antagonism. It has lower emotional blunting potential based on its pharmacology.

Strategy 3: Augmentation With Bupropion

Rather than switching completely, adding bupropion to your existing SSRI can address emotional blunting while maintaining the antidepressant effect you’re getting.

How it works: Bupropion adds dopaminergic and noradrenergic activity that may counteract the emotional-dampening effects of serotonin enhancement.

Evidence: Bupropion augmentation is well-established for improving SSRI response overall and is commonly used in clinical practice for emotional blunting, though specific trials for this indication are limited.

Typical approach: Bupropion 150mg/day of the sustained-release (SR) or extended-release (XL) formulation is a common starting point, with potential increase to 300mg/day.

Benefits: This approach lets you keep your current SSRI if it’s helping your depression while adding something to restore emotional engagement. It may also help with fatigue, concentration, and sexual dysfunction if those are issues.

Strategy 4: Other Augmentation Options

Beyond bupropion, several other augmentation strategies have been used for emotional blunting, though with less evidence:

Stimulant medications like methylphenidate (Ritalin) or modafinil (Provigil) can be added in some cases. They increase dopamine activity and may counteract emotional blunting. However, they have potential for side effects and, in the case of methylphenidate, dependency concerns.

Dopamine agonists like pramipexole or ropinirole (typically used for Parkinson’s disease and restless legs syndrome) have emerging evidence for augmentation in depression and could theoretically help with emotional blunting through dopamine enhancement. These are less commonly used and carry their own side effect risks.

Strategy 5: Non-Pharmacological Approaches

While medication adjustments are often central, non-pharmacological strategies can support emotional recovery:

Behavioral activation involves deliberately engaging in activities that have historically been emotionally meaningful or pleasurable, even when they don’t immediately feel rewarding. The theory is that repeated engagement can help rebuild emotional responsiveness over time.

Mindfulness practices may help increase awareness of subtle emotional experiences that blunting tends to obscure. Learning to notice and attend to emotional nuances can help you reconnect with your emotional life.

Psychotherapy can be valuable, particularly for processing the experience of emotional blunting itself, maintaining relationship connections during this period, and working on depression from angles that medication doesn’t address.

Exercise has well-documented effects on mood and emotional well-being. Regular physical activity may help maintain emotional range even when medication is dampening it somewhat.

Part 6: Creating Your Personal Action Plan

Managing emotional blunting effectively requires a personalized approach. Here’s a framework for working toward a solution:

Step 1: Clarify What You’re Experiencing

Use the information in Part 3 to differentiate between medication-induced emotional blunting, residual depression, and potentially other factors. Consider keeping a brief daily log of your emotional experiences for a few weeks to identify patterns.

Questions to reflect on:

• What emotional changes have I noticed?
• When did they start?
• How do they relate to my medication timing and dose changes?
• What aspects of emotional life are most affected?

Step 2: Assess the Impact

Consider how much emotional blunting is affecting your quality of life:

• Is it a minor nuisance or a significant problem?
• How is it affecting your relationships?
• How is it affecting your work and creativity?
• Would you describe your current state as acceptable or unacceptable?

The level of impact influences how aggressive your treatment approach should be.

Step 3: Communicate With Your Provider

Bring your observations to your provider. Be specific about:

• What emotional changes you’ve noticed
• When they started relative to medication changes
• How severely they’re affecting your life
• What you’ve already tried, if anything

Ask about the options discussed in this guide. Not every option will be appropriate for your specific situation, but having an informed conversation will help you and your provider develop the best plan.

Step 4: Try Interventions Systematically

Rather than changing multiple things at once, make one change at a time and assess the effects before making additional changes. This helps you understand what’s actually helping.

A reasonable sequence might be:

1. If you’re on a higher dose than necessary, try a modest dose reduction first (with provider guidance)
2. If dose reduction isn’t feasible or doesn’t help, consider bupropion augmentation
3. If augmentation isn’t sufficient, consider switching medications
4. Throughout, incorporate non-pharmacological strategies

Step 5: Monitor and Adjust

Emotional blunting often responds to treatment over weeks, not days. Give interventions adequate time to work (typically 2 to 4 weeks minimum) before concluding they haven’t helped.

Keep monitoring:

• Emotional range and responsiveness
• Depression symptoms (to ensure they remain controlled)
• Other side effects (some interventions may help one thing while causing another)

The goal is finding the optimal balance for you personally.

Part 7: What to Expect

Timeline for Improvement

If you’re reducing your SSRI dose, you may notice emotional changes within a few days to weeks, though the full effect on depression needs monitoring over several weeks.

If you’re adding bupropion, some effects may be noticeable within the first week or two, but full benefit typically takes 4 to 6 weeks.

If you’re switching medications, expect a transition period. The timeline depends on how the switch is managed (cross-taper vs. sequential switch), but emotional improvements often become apparent within 2 to 4 weeks on the new medication.

What “Better” Looks Like

The goal isn’t to restore the emotional intensity of depression (which can include very intense negative emotions). The goal is to restore the normal range of human emotional experience: genuine happiness when good things happen, appropriate sadness when things are hard, excitement about things you care about, and connection with the people in your life.

People who successfully address emotional blunting often describe feeling “like themselves again” or “present in my life in a way I wasn’t before.”

When It’s More Complicated

Sometimes emotional blunting doesn’t respond readily to the usual interventions. This might indicate:

• Residual depression that needs additional treatment
• A complex medication situation that requires specialist input
• Other factors (thyroid issues, hormonal changes, other medical conditions) contributing to emotional symptoms
• Need for a different approach to depression treatment altogether

If straightforward interventions aren’t helping, consider asking for a referral to a psychiatrist if you’re not already seeing one, or seeking a second opinion.

Part 8: Special Considerations

Emotional Blunting and Sexual Dysfunction

Emotional blunting and sexual dysfunction frequently occur together in people taking SSRIs. This makes sense given the overlapping mechanisms (both involve serotonin’s effects on dopamine and general reward/pleasure pathways).

If you’re experiencing both, this is actually useful information. It suggests that interventions targeting the dopamine-serotonin balance (like bupropion augmentation or switching to bupropion) may help both problems simultaneously.

When Blunting Seems Like a Benefit

Some people find that reduced emotional reactivity is actually helpful, at least initially. If you’ve been overwhelmed by intense emotions, anxiety, or emotional pain, the dampening effect of medication can feel like relief.

This is valid in the short term. But over time, most people find that an overly restricted emotional range isn’t sustainable for a fulfilling life. The goal of treatment is to be able to experience and manage emotions, not to eliminate them.

If you’re in a phase where emotional dampening feels protective, that’s okay. Just be aware that this may change, and that options exist when you’re ready for more emotional range.

Long-Term Considerations

Some research suggests that long-term SSRI use may lead to increasing emotional blunting over time for some people. If you’ve been on an SSRI for years and notice your emotional range has gradually narrowed, this may be worth discussing with your provider.

However, most people who benefit from antidepressants continue to benefit over time. The key is monitoring your experience and being willing to make adjustments when needed.

Frequently Asked Questions

Is emotional blunting a sign my SSRI isn’t working? Not exactly. Emotional blunting often occurs when the SSRI is working for depression (the intense sadness is better) but is causing an unwanted side effect (emotional dampening). These are two separate phenomena that can occur simultaneously.

Will emotional blunting go away on its own? Unlike some SSRI side effects that improve with time, emotional blunting typically persists as long as you’re on the medication at a given dose. Active intervention is usually necessary.

How do I know if it’s the medication or residual depression? Timing is the key clue. If emotional difficulties predated medication, depression may be the primary factor. If your emotional range was more normal before medication and changed after starting, the medication is likely contributing. See Part 3 for a detailed framework.

Can emotional blunting affect my relationships? Yes, significantly. Partners may perceive emotional blunting as disengagement or lack of caring. Open communication about what you’re experiencing can help prevent misunderstandings while you work on solutions.

Is some emotional blunting expected on antidepressants? It’s common, but not inevitable or necessary. Many people take antidepressants without significant emotional blunting, and those who experience it usually have options for addressing it.

Can therapy help with medication-induced emotional blunting? Therapy can’t reverse pharmacological effects, but it can help you maintain connections and cope while you work on medication solutions. It can also address underlying depression that may be contributing.

Which antidepressant is best for avoiding emotional blunting? Bupropion has the lowest risk of emotional blunting because it doesn’t work through serotonin. Among other options, vortioxetine and mirtazapine may have lower blunting risk than pure SSRIs.

What if I lower my dose and my depression comes back? This is why dose reduction should be done carefully and with monitoring. If depression symptoms return, you’ll need a different approach, possibly augmentation rather than dose reduction. Having a plan with your provider is important.

How long does it take for emotional blunting to improve after changing treatment? Depending on the intervention, improvement often begins within 2 to 4 weeks. Full benefit may take longer. Give interventions adequate time before concluding they haven’t helped.

Can I feel emotions AND stay depression-free? Absolutely. This is the goal of treatment. With the right approach, most people can achieve both adequate depression control and meaningful emotional engagement with life.

Key Takeaways

1. Emotional blunting is common on SSRIs, affecting 40% to 60% (or more) of patients, but it’s underrecognized because patients often don’t report it.

1. It’s a side effect, not a treatment goal. Relief from depression should include the ability to experience the full range of emotions, not just the absence of intense suffering.

1. Timing helps distinguish medication effects from depression. If emotional range was normal before medication and changed after starting, the medication is likely contributing.

1. Multiple evidence-based solutions exist, including dose reduction, augmentation with bupropion, and switching to medications like bupropion, vortioxetine, or mirtazapine.

1. Bupropion augmentation (150 to 300mg) is often effective and allows you to continue your current SSRI while restoring emotional engagement.

1. Don’t accept emotional blunting as the price of treating depression. With proper attention, most people can find an approach that controls depression while preserving emotional richness.

1. Work collaboratively with your provider. Share what you’re experiencing, discuss the options, and develop a plan that addresses your specific situation.

A Note on Working With Your Provider

The information in this guide is meant to help you understand your options and have informed conversations with your healthcare provider. It’s not a substitute for personalized medical advice.

Before making any changes to your medication, discuss your plans with the provider managing your antidepressant treatment. They can help you weigh the options based on your specific situation, monitor your response to any changes, and adjust the plan as needed.

If you’re experiencing emotional blunting and want to explore integrative approaches to restoring your emotional life while maintaining mental wellness, consider seeking care from a provider who takes these concerns seriously and offers comprehensive treatment options.

References

1. Goodwin GM, Price J, de Bodinat C, Laredo J. Emotional blunting with antidepressant treatments: a survey among depressed patients. J Affect Disord. 2017;221:31-35. doi:10.1016/j.jad.2017.05.048. PubMed

1. Price J, Cole V, Goodwin GM. Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. Br J Psychiatry. 2009;195(3):211-217. doi:10.1192/bjp.bp.108.051110. PubMed

1. Read J, Cartwright C, Gibson K. Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Res. 2014;216(1):67-73. doi:10.1016/j.psychres.2014.01.042. PubMed

1. Fava M, Graves LM, Benazzi F, et al. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J Clin Psychiatry. 2006;67(11):1754-1759. doi:10.4088/jcp.v67n1113. PubMed

1. Nutt D, Demyttenaere K, Janka Z, et al. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol. 2007;21(5):461-471. doi:10.1177/0269881106069938. PubMed

1. Harmer CJ, Goodwin GM, Cowen PJ. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry. 2009;195(2):102-108. doi:10.1192/bjp.bp.108.051193. PubMed

1. Sansone RA, Sansone LA. SSRI-induced indifference. Psychiatry (Edgmont). 2010;7(10):14-18. PubMed

1. Barnhart WJ, Makela EH, Latocha MJ. SSRI-induced apathy syndrome: a clinical review. J Psychiatr Pract. 2004;10(3):196-199. doi:10.1097/00131746-200405000-00010. PubMed

1. Opbroek A, Delgado PL, Laukes C, et al. Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses? Int J Neuropsychopharmacol. 2002;5(2):147-151. doi:10.1017/S1461145702002870. PubMed

1. Bolling MY, Kohlenberg RJ. Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction. Psychother Psychosom. 2004;73(6):380-385. doi:10.1159/000080392. PubMed

1. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53(8):649-659. doi:10.1016/s0006-3223(03)00231-2. PubMed

1. Padala PR, Padala KP, Majagi AS, Garber AJ, Dennis RA, Sullivan DH. Selective serotonin reuptake inhibitors-associated apathy syndrome: a cross-sectional study. Medicine (Baltimore). 2020;99(33):e21497. doi:10.1097/MD.0000000000021497. PubMed

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult with your healthcare provider before making changes to your medication or treatment plan. Never stop or adjust your antidepressant without medical supervision.